Skip to main content
OpenTrials
Completed

NCT Number: NCT06172049

Incidence of Colorectal Cancer in Southwest China: Based on SCC Database

To evaluate recent trends in CRC incidence, treatment, and survival in the Southwest China.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The epidemiological feature of colorectal cancer (CRC) showed different trends among countries. Studying the epidemiological and management characteristics between China and the US has important implications for understanding the current status of cancer occurrence, treatment and survival. we established the Southwest China Colorectal (SCC) database, aiming to provide reference information on the diagnosis and management of CRC in China.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of colorectal cancer;
  • Received treatment in medical institutions;
  • Regular follow-up after the diagnosis.

Exclusion criteria

Patients who lost to follow-up

Treatment and study plan

Treatment

Other

the actual treatment CRC patients have reveived

Primary outcomes

  1. Survival

    Time frame: From inclusion until date of death from any cause, or untile the 2023-10-31

    Overall survival (OS) untile the end of follow up

Sponsors and collaborators

Lead sponsor

West China Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2023
First posted
Dec 15, 2023
Registry last updated
Dec 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.